245
Views
10
CrossRef citations to date
0
Altmetric
Clinical focus: Clinical Immunology & Infectious Diseases - Original research

Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 626-638 | Received 07 Dec 2020, Accepted 12 May 2021, Published online: 16 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Moying Li, Timo Itzel, Nathally Espinosa Montagut, Thomas Falconer, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias Philip Ebert, George Hripcsak & Andreas Teufel. (2023) Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology 58:12, pages 1505-1513.
Read now

Articles from other publishers (9)

Kenta Yamamoto, Takashi Honda, Yosuke Inukai, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura & Hiroki Kawashima. (2024) Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease. Microorganisms 12:3, pages 610.
Crossref
Fereshteh Pashayee-khamene, Behzad Hatami, Makan Cheraghpour & Zahra Yari. (2023) Keeping an eye on the nutrition: The importance of nutrition management on cardiometabolic risk factors in cirrhotic patients. Clinical Nutrition ESPEN 58, pages 186-192.
Crossref
Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng & Qiang Zhu. (2023) The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study. European Journal of Gastroenterology & Hepatology 35:8, pages 889-898.
Crossref
Meral Kayikcioglu, Hasan Selcuk Ozkan & Lale Tokgozoglu. (2023) Are we seeing the light at the end of the tunnel for high lipoprotein(a)? Lipoprotein(a). European Atherosclerosis Journal 1:3.
Crossref
Yi-Yan Zhang, Le Wang, Xiao-Dong Shao, Yong-Guo Zhang, Shao-Ze Ma, Meng-Yuan Peng, Shi-Xue Xu, Yue Yin, Xiao-Zhong Guo & Xing-Shun Qi. (2023) Effects of postoperative use of proton pump inhibitors on gastrointestinal bleeding after endoscopic variceal treatment during hospitalization. World Journal of Gastrointestinal Surgery 15:1, pages 82-93.
Crossref
Mo-Jong Kim, Jung-Hee Kim, Jang-Han Jung, Sung-Eun Kim, Hyoung-Su Kim, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Ki Suk, Dong Kim, Eun-Kyoung Choi & Ji-Won Park. (2023) Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy. Diagnostics 13:3, pages 333.
Crossref
Raja Ganesan, Vasantha-Srinivasan Prabhakaran & Abilash Valsala Gopalakrishnan. (2022) Metabolomic Signatures in Doxorubicin-Induced Metabolites Characterization, Metabolic Inhibition, and Signaling Pathway Mechanisms in Colon Cancer HCT116 Cells. Metabolites 12:11, pages 1047.
Crossref
Peng Wang, Yuqi Wang, Hui Liu, Xiaoxu Han, Yunyun Yi, Xin Wang & Xin Li. (2022) Role of triglycerides as a predictor of autoimmune hepatitis with cirrhosis. Lipids in Health and Disease 21:1.
Crossref
Minjian Dong, Qingqing Yi, Danjie Shen, Jiapin Yan, Haowei Jiang, Jiaojiao Xie, Liangcai Zhao & Hongchang Gao. (2022) A combined metabolomics and molecular biology approach to reveal hepatic injury and underlying mechanisms after chronic l-lactate exposure in mice. Computational and Structural Biotechnology Journal 20, pages 3935-3945.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.